Home › Companies › CRISPR THERAPEUTICS AG › 2024-2025

CRISPR THERAPEUTICS AG 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CRISPR THERAPEUTICS AG’s Form 8-K (Item 5.07 on EDGAR). Page generated 04 October 2026.

50Reported items
449Asset managers
4,275Fund votes
2025-06-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CRISPR THERAPEUTICS AG in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CRISPR THERAPEUTICS AG

These tallies are CRISPR THERAPEUTICS AG’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CRISPR THERAPEUTICS AG — official shareholder meeting results, meeting held 2025-06-05
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Samarth Kulkarni, Ph.D.	40,043,203	785,309	107,801	--	20,822,113	Majority: yes
Elect Director: Ali Behbahani, M.D.	29,800,902	11,023,256	112,155	--	20,822,113	Majority: yes
Elect Director: Maria Fardis, Ph.D.	39,931,396	898,012	106,905	--	20,822,113	Majority: yes
Elect Director: H. Edward Fleming Jr., M.D.	39,553,960	1,273,549	108,804	--	20,822,113	Majority: yes
Elect Director: Simeon J. George, M.D.	39,938,669	894,244	103,400	--	20,822,113	Majority: yes
Elect Director: John T. Greene	39,324,918	1,499,057	112,338	--	20,822,113	Majority: yes
Elect Director: Katherine A. High, M.D.	39,882,598	946,656	107,059	--	20,822,113	Majority: yes
Elect Director: Sandesh Mahatme, LL.M.	39,915,991	918,369	101,953	--	20,822,113	Majority: yes
Elect Director: Christian Rommel, Ph.D.	39,928,435	899,491	108,387	--	20,822,113	Majority: yes
Elect Director: Douglas A. Treco, Ph.D.	38,935,855	1,892,354	108,104	--	20,822,113	Majority: yes
Elect Director: Briggs W. Morrison, M.D.	39,667,043	1,160,681	108,589	--	20,822,113	Majority: yes
Elect Director: Ali Behbahani, M.D.	29,606,114	11,206,197	124,002	--	20,822,113	Majority: yes
Elect Director: H. Edward Fleming Jr., M.D.	39,457,808	1,356,562	121,943	--	20,822,113	Majority: yes
Elect Director: John T. Greene	39,257,150	1,550,619	128,544	--	20,822,113	Majority: yes
Elect Director: Briggs W. Morrison, M.D.	39,579,346	1,234,698	122,269	--	20,822,113	Majority: yes

Source: CRISPR THERAPEUTICS AG, Form 8-K — read the filing on EDGAR.

How asset managers voted at the CRISPR THERAPEUTICS AG 2024-2025 meeting

Each item below shows how the 449 asset managers that disclosed a CRISPR THERAPEUTICS AG vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CRISPR THERAPEUTICS AG’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-05.

Combines 12 wordings of this item as funds reported it.

69% fund support · no official result

FOR 69%AGAINST 31%

The 407 asset managers below cast 69% of the shares they voted on this item FOR (26,971,103 for, 11,970,680 against).

FOR: 26,971,103 (69.2%)AGAINST: 11,970,680 (30.7%)ABSTAIN: 2,830 (0.0%)NOT VOTED: 3,149 (0.0%)0: 1,935 (0.0%)

Largest asset managers voting on “Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securi” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	11,661,256	0	For
ARK ETF Trust	9,517,585	0	For
T. Rowe Price	0	4,410,745	Against
Nikko Asset Management Co., Ltd.	0	2,539,889	Against
NEA Management Company, LLC	1,590,002	0	For
EcoR1 Capital, LLC	1,389,276	0	For
SR ONE CAPITAL MANAGEMENT, LP	1,048,951	0	For
Loomis Sayles	0	673,254	Against
State Street	0	563,643	Against
Versant Venture Management, LLC	500,028	0	For
Fidelity	0	359,100	Against
Contrarius Group Holdings Ltd	317,448	0	For
Jackson National	0	283,472	Against
CAPITAL ADVISORS INC/OK	270,173	0	For
Vanguard	0	226,332	Against
ARK Investment Management LLC	222,868	0	For
STATE OF MICHIGAN RETIREMENT SYSTEM	0	222,852	Against
Vestmark Advisory Solutions, Inc.	0	219,430	Against
MARSHALL WACE, LLP	0	215,172	Against
BlackRock	5,508	194,201	Against
Charles Schwab	0	177,896	Against
Two Sigma	0	160,369	Against
Northern Trust	0	150,363	Against
Lazard	0	87,507	Against
RBC Capital Markets, LLC	0	87,412	Against

Showing the 25 largest of 407 asset managers. See all 407 in the interactive database.

2. Non-binding advisory vote on the 2024 Compensation Report.

COMPENSATION

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

94% fund support · no official result

FOR 94%

The 70 asset managers below cast 94% of the shares they voted on this item FOR (11,266,946 for, 722,274 against).

FOR: 11,266,946 (94.0%)AGAINST: 722,274 (6.0%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Non-binding advisory vote on the 2024 Compensation Report.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
SR ONE CAPITAL MANAGEMENT, LP	1,048,951	0	For
Versant Venture Management, LLC	500,028	0	For
Jackson National	0	283,472	Against
BlackRock	5,508	194,201	Against
Charles Schwab	0	88,948	Against
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
WESTWOOD HOLDINGS GROUP INC	38,843	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	0	22,300	Against
Global X	0	22,293	Against
ADVISORS SERIES TRUST	17,310	0	For
Sand Hill Global Advisors, LLC	0	8,655	Against
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	0	2,134	Against
MERCER GLOBAL ADVISORS INC /ADV	1,824	0	For
Abundance Wealth Counselors	0	1,742	Against
Evercore Wealth Management, LLC	0	1,400	Against
JPMorgan	0	1,394	Against
First Trust	687	564	For
Bath Savings Trust Co	1,225	0	For

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

3. Approval of increasing the maximum size of the Board of Directors.

OTHER

Meeting held 2025-06-05.

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 99.9% of the shares they voted on this item FOR (18,323,987 for, 0 against).

FOR: 18,323,987 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Approval of increasing the maximum size of the Board of Directors.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Vote
ARK ETF Trust	9,517,585	For
Capital Group	5,493,229	For
T. Rowe Price	1,735,454	For
Jackson National	283,472	For
State Street	233,974	For
Vanguard	221,223	For
Fidelity	151,641	For
Charles Schwab	88,948	For
Natixis	83,372	For
Equitable	56,946	For
Lincoln Financial	55,545	For
AMERICAN BEACON FUNDS	53,357	For
RMB INVESTORS TRUST	39,367	For
ARK Venture Fund	38,162	For
Investment Managers Series Trust II	33,268	For
Direxion Shares ETF Trust	28,769	For
Capitol Series Trust	22,300	For
Global X	22,293	For
Northern Trust	22,183	For
MassMutual	19,636	For
ADVISORS SERIES TRUST	17,310	For
American Century	16,402	For
Nationwide	16,111	For
Northwestern Mutual	14,200	For
Blackstone Alternative Investment Funds	12,700	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

4. Discharge of the members of the Board of Directors and the Executive Committee.

OTHER

Meeting held 2025-06-05.

99.9% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 99.9% of the shares they voted on this item FOR (18,323,987 for, 0 against).

FOR: 18,323,987 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Discharge of the members of the Board of Directors and the Executive Committee.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Vote
ARK ETF Trust	9,517,585	For
Capital Group	5,493,229	For
T. Rowe Price	1,735,454	For
Jackson National	283,472	For
State Street	233,974	For
Vanguard	221,223	For
Fidelity	151,641	For
Charles Schwab	88,948	For
Natixis	83,372	For
Equitable	56,946	For
Lincoln Financial	55,545	For
AMERICAN BEACON FUNDS	53,357	For
RMB INVESTORS TRUST	39,367	For
ARK Venture Fund	38,162	For
Investment Managers Series Trust II	33,268	For
Direxion Shares ETF Trust	28,769	For
Capitol Series Trust	22,300	For
Global X	22,293	For
Northern Trust	22,183	For
MassMutual	19,636	For
ADVISORS SERIES TRUST	17,310	For
American Century	16,402	For
Nationwide	16,111	For
Northwestern Mutual	14,200	For
Blackstone Alternative Investment Funds	12,700	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

5. i Re-election of Christian Rommel, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 39,928,435AGAINST: 899,491

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Christian Rommel, Ph.D.”): 39,928,435 for, 899,491 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,360,924 outstanding shares: 46.2% for, 1% against (47.3% of the company cast a for/against vote).

The 51 asset managers below cast 98% of the shares they voted on this item FOR (17,924,568 for, 396,549 against).

FOR 98%

FOR: 17,924,568 (97.8%)AGAINST: 396,549 (2.2%)ABSTAIN: 2,840 (0.0%)

Largest asset managers voting on “i Re-election of Christian Rommel, Ph.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
Jackson National	105,532	177,940	Against
State Street	233,974	0	For
Vanguard	221,223	0	For
Fidelity	151,641	0	For
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	39,367	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	28,769	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
ADVISORS SERIES TRUST	17,310	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

6. j Re-election of Douglas A. Treco, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 38,935,855AGAINST: 1,892,354

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Douglas A. Treco, Ph.D.”): 38,935,855 for, 1,892,354 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,360,924 outstanding shares: 45.1% for, 2% against (47.3% of the company cast a for/against vote).

The 51 asset managers below cast 96% of the shares they voted on this item FOR (17,647,186 for, 676,771 against).

FOR 96%

FOR: 17,647,186 (96.3%)AGAINST: 676,771 (3.7%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “j Re-election of Douglas A. Treco, Ph.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
Jackson National	105,532	177,940	Against
State Street	0	233,974	Against
Vanguard	221,223	0	For
Fidelity	115,415	36,226	For
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	39,367	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	28,769	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
ADVISORS SERIES TRUST	17,310	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

7. g Re-election of Katherine A. High, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 39,882,598AGAINST: 946,656

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Katherine A. High, M.D.”): 39,882,598 for, 946,656 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,360,924 outstanding shares: 46.2% for, 1% against (47.3% of the company cast a for/against vote).

The 51 asset managers below cast 98% of the shares they voted on this item FOR (17,927,408 for, 396,549 against).

FOR 98%

FOR: 17,927,408 (97.8%)AGAINST: 396,549 (2.2%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “g Re-election of Katherine A. High, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
Jackson National	105,532	177,940	Against
State Street	233,974	0	For
Vanguard	221,223	0	For
Fidelity	151,641	0	For
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	39,367	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	28,769	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
ADVISORS SERIES TRUST	17,310	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

8. c Re-election of Maria Fardis, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 39,931,396AGAINST: 898,012

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Maria Fardis, Ph.D.”): 39,931,396 for, 898,012 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,360,924 outstanding shares: 46.2% for, 1% against (47.3% of the company cast a for/against vote).

The 51 asset managers below cast 98% of the shares they voted on this item FOR (17,927,408 for, 396,549 against).

FOR 98%

FOR: 17,927,408 (97.8%)AGAINST: 396,549 (2.2%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “c Re-election of Maria Fardis, Ph.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
Jackson National	105,532	177,940	Against
State Street	233,974	0	For
Vanguard	221,223	0	For
Fidelity	151,641	0	For
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	39,367	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	28,769	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
ADVISORS SERIES TRUST	17,310	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

9. Election or re-election of the members to the Board of Directors and the Chairman: 4.a Re-election of Samarth Kulkarni, Ph.D., as member and Chairman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 40,043,203AGAINST: 785,309

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Samarth Kulkarni, Ph.D.”): 40,043,203 for, 785,309 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,360,924 outstanding shares: 46.4% for, 1.0% against (47.3% of the company cast a for/against vote).

The 51 asset managers below cast 99.8% of the shares they voted on this item FOR (18,301,657 for, 22,300 against).

FOR 99.8%

FOR: 18,301,657 (99.9%)AGAINST: 22,300 (0.1%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Election or re-election of the members to the Board of Directors and the Chairman: 4.a Re-election of Samarth ” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
Jackson National	283,472	0	For
State Street	233,974	0	For
Vanguard	221,223	0	For
Fidelity	151,641	0	For
Charles Schwab	88,948	0	For
Natixis	83,372	0	For
Equitable	56,946	0	For
Lincoln Financial	55,545	0	For
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	39,367	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	28,769	0	For
Capitol Series Trust	0	22,300	Against
Global X	22,293	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
ADVISORS SERIES TRUST	17,310	0	For
American Century	16,402	0	For
Nationwide	16,111	0	For
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

10. h Re-election of Sandesh Mahatme, LL.M.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 39,915,991AGAINST: 918,369

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Sandesh Mahatme, LL.M.”): 39,915,991 for, 918,369 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,360,924 outstanding shares: 46.2% for, 1% against (47.3% of the company cast a for/against vote).

The 51 asset managers below cast 98% of the shares they voted on this item FOR (17,927,408 for, 396,549 against).

FOR 98%

FOR: 17,927,408 (97.8%)AGAINST: 396,549 (2.2%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “h Re-election of Sandesh Mahatme, LL.M.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
Jackson National	105,532	177,940	Against
State Street	233,974	0	For
Vanguard	221,223	0	For
Fidelity	151,641	0	For
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	39,367	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	28,769	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
ADVISORS SERIES TRUST	17,310	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

11. e Re-election of Simeon J. George, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 39,938,669AGAINST: 894,244

CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Simeon J. George, M.D.”): 39,938,669 for, 894,244 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,360,924 outstanding shares: 46.2% for, 1% against (47.3% of the company cast a for/against vote).

The 51 asset managers below cast 98% of the shares they voted on this item FOR (17,927,408 for, 396,549 against).

FOR 98%

FOR: 17,927,408 (97.8%)AGAINST: 396,549 (2.2%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “e Re-election of Simeon J. George, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
Jackson National	105,532	177,940	Against
State Street	233,974	0	For
Vanguard	221,223	0	For
Fidelity	151,641	0	For
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	39,367	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	28,769	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
ADVISORS SERIES TRUST	17,310	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

12. Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2024.

OTHER

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 50 asset managers below cast 99.9% of the shares they voted on this item FOR (18,323,887 for, 0 against).

FOR: 18,323,887 (100.0%)AGAINST: 0 (0.0%)

Largest asset managers voting on “Approval of the Swiss management report, the consolidated financial statements and the statutory financial sta” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Vote
ARK ETF Trust	9,517,585	For
Capital Group	5,493,229	For
T. Rowe Price	1,735,454	For
Jackson National	283,472	For
State Street	233,974	For
Vanguard	221,223	For
Fidelity	151,641	For
Charles Schwab	88,948	For
Natixis	83,372	For
Equitable	56,946	For
Lincoln Financial	55,545	For
AMERICAN BEACON FUNDS	53,357	For
RMB INVESTORS TRUST	39,367	For
ARK Venture Fund	38,162	For
Investment Managers Series Trust II	33,268	For
Direxion Shares ETF Trust	28,769	For
Capitol Series Trust	22,300	For
Global X	22,293	For
Northern Trust	22,183	For
MassMutual	19,636	For
ADVISORS SERIES TRUST	17,310	For
American Century	16,402	For
Nationwide	16,111	For
Northwestern Mutual	14,200	For
Blackstone Alternative Investment Funds	12,700	For

Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.

13. Approval of the appropriation of financial results.

OTHER

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 50 asset managers below cast 99.9% of the shares they voted on this item FOR (18,323,887 for, 0 against).

FOR: 18,323,887 (100.0%)AGAINST: 0 (0.0%)

Largest asset managers voting on “Approval of the appropriation of financial results.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Vote
ARK ETF Trust	9,517,585	For
Capital Group	5,493,229	For
T. Rowe Price	1,735,454	For
Jackson National	283,472	For
State Street	233,974	For
Vanguard	221,223	For
Fidelity	151,641	For
Charles Schwab	88,948	For
Natixis	83,372	For
Equitable	56,946	For
Lincoln Financial	55,545	For
AMERICAN BEACON FUNDS	53,357	For
RMB INVESTORS TRUST	39,367	For
ARK Venture Fund	38,162	For
Investment Managers Series Trust II	33,268	For
Direxion Shares ETF Trust	28,769	For
Capitol Series Trust	22,300	For
Global X	22,293	For
Northern Trust	22,183	For
MassMutual	19,636	For
ADVISORS SERIES TRUST	17,310	For
American Century	16,402	For
Nationwide	16,111	For
Northwestern Mutual	14,200	For
Blackstone Alternative Investment Funds	12,700	For

Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.

14. Re-election of the auditors.

AUDIT-RELATED

Meeting held 2025-06-05.

99.9% fund support · no official result

FOR 99.8%

The 50 asset managers below cast 99.9% of the shares they voted on this item FOR (18,301,363 for, 224 against).

FOR: 18,301,363 (99.9%)AGAINST: 224 (0.0%)ABSTAIN: 22,300 (0.1%)

Largest asset managers voting on “Re-election of the auditors.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Abstain	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
Jackson National	283,472	0	For
State Street	233,974	0	For
Vanguard	221,223	0	For
Fidelity	151,641	0	For
Charles Schwab	88,948	0	For
Natixis	83,372	0	For
Equitable	56,946	0	For
Lincoln Financial	55,545	0	For
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	39,367	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	28,769	0	For
Capitol Series Trust	0	22,300	Abstain
Global X	22,293	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
ADVISORS SERIES TRUST	17,310	0	For
American Century	16,402	0	For
Nationwide	16,111	0	For
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For

Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.

15. Re-election of the independent voting rights representative.

CORPORATE GOVERNANCE

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 50 asset managers below cast 99.9% of the shares they voted on this item FOR (18,323,887 for, 0 against).

FOR: 18,323,887 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Re-election of the independent voting rights representative.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Vote
ARK ETF Trust	9,517,585	For
Capital Group	5,493,229	For
T. Rowe Price	1,735,454	For
Jackson National	283,472	For
State Street	233,974	For
Vanguard	221,223	For
Fidelity	151,641	For
Charles Schwab	88,948	For
Natixis	83,372	For
Equitable	56,946	For
Lincoln Financial	55,545	For
AMERICAN BEACON FUNDS	53,357	For
RMB INVESTORS TRUST	39,367	For
ARK Venture Fund	38,162	For
Investment Managers Series Trust II	33,268	For
Direxion Shares ETF Trust	28,769	For
Capitol Series Trust	22,300	For
Global X	22,293	For
Northern Trust	22,183	For
MassMutual	19,636	For
ADVISORS SERIES TRUST	17,310	For
American Century	16,402	For
Nationwide	16,111	For
Northwestern Mutual	14,200	For
Blackstone Alternative Investment Funds	12,700	For

Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.

16. Transact any other business that may properly come before the 2025 Annual General Meeting or any adjournment or postponement thereof.

CORPORATE GOVERNANCE

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

52.7% fund support · no official result

FOR 52.7%AGAINST 47.3%

The 50 asset managers below cast 52.7% of the shares they voted on this item FOR (9,662,324 for, 8,658,723 against).

FOR: 9,662,324 (52.7%)AGAINST: 8,658,723 (47.3%)ABSTAIN: 2,840 (0.0%)

Largest asset managers voting on “Transact any other business that may properly come before the 2025 Annual General Meeting or any adjournment o” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Capital Group	0	5,493,229	Against
T. Rowe Price	0	1,735,454	Against
Jackson National	0	283,472	Against
State Street	0	233,974	Against
Vanguard	0	221,223	Against
Fidelity	0	151,641	Against
Charles Schwab	0	88,948	Against
Natixis	0	83,372	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
AMERICAN BEACON FUNDS	53,357	0	For
RMB INVESTORS TRUST	0	39,367	Against
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Direxion Shares ETF Trust	0	28,769	Against
Capitol Series Trust	0	22,300	Against
Global X	0	22,293	Against
Northern Trust	0	22,183	Against
MassMutual	0	19,636	Against
ADVISORS SERIES TRUST	17,310	0	For
American Century	0	16,402	Against
Nationwide	0	16,111	Against
Northwestern Mutual	0	14,200	Against
Blackstone Alternative Investment Funds	0	12,700	Against

Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.

17. Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.

COMPENSATION

Meeting held 2025-06-05.

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 37 asset managers below cast 99.9% of the shares they voted on this item FOR (13,338,682 for, 310 against).

FOR: 13,338,682 (100.0%)AGAINST: 310 (0.0%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
NEA Management Company, LLC	1,590,002	0	For
SR ONE CAPITAL MANAGEMENT, LP	1,048,951	0	For
Versant Venture Management, LLC	500,028	0	For
Jackson National	283,472	0	For
Charles Schwab	88,948	0	For
Natixis	83,372	0	For
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
ADVISORS SERIES TRUST	17,310	0	For
Janney Montgomery Scott LLC	10,819	0	For
BlackRock	10,022	0	For
Loomis Sayles	6,635	0	For
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	2,134	0	For
JPMorgan	1,394	0	For
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	410	0	For
EXENCIAL WEALTH ADVISORS, LLC	318	0	For
Rodgers Brothers Inc.	0	300	Against
Amplify ETF Trust	224	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

18. Binding vote on maximum non- performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026.

COMPENSATION

Meeting held 2025-06-05.

Combines 5 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 36 asset managers below cast 98% of the shares they voted on this item FOR (13,039,291 for, 299,491 against).

FOR: 13,039,291 (97.8%)AGAINST: 299,491 (2.2%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Binding vote on maximum non- performance-related compensation for members of the Executive Committee from July” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
NEA Management Company, LLC	1,590,002	0	For
SR ONE CAPITAL MANAGEMENT, LP	1,048,951	0	For
Versant Venture Management, LLC	500,028	0	For
Jackson National	86,878	196,594	Against
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
ADVISORS SERIES TRUST	17,310	0	For
Janney Montgomery Scott LLC	10,819	0	For
BlackRock	0	10,022	Against
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	0	2,134	Against
JPMorgan	1,394	0	For
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	410	0	For
EXENCIAL WEALTH ADVISORS, LLC	318	0	For
Rodgers Brothers Inc.	0	300	Against
Amplify ETF Trust	0	224	Against

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

19. Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025.

COMPENSATION

Meeting held 2025-06-05.

Combines 5 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 36 asset managers below cast 98% of the shares they voted on this item FOR (13,039,291 for, 299,491 against).

FOR: 13,039,291 (97.8%)AGAINST: 299,491 (2.2%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Binding vote on maximum variable compensation for members of the Executive Committee for the current year endi” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
NEA Management Company, LLC	1,590,002	0	For
SR ONE CAPITAL MANAGEMENT, LP	1,048,951	0	For
Versant Venture Management, LLC	500,028	0	For
Jackson National	86,878	196,594	Against
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
ADVISORS SERIES TRUST	17,310	0	For
Janney Montgomery Scott LLC	10,819	0	For
BlackRock	0	10,022	Against
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	0	2,134	Against
JPMorgan	1,394	0	For
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	410	0	For
EXENCIAL WEALTH ADVISORS, LLC	318	0	For
Rodgers Brothers Inc.	0	300	Against
Amplify ETF Trust	0	224	Against

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

20. Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.

COMPENSATION

Meeting held 2025-06-05.

Combines 4 wordings of this item as funds reported it.

96% fund support · no official result

FOR 96%

The 30 asset managers below cast 96% of the shares they voted on this item FOR (11,314,158 for, 423,006 against).

FOR: 11,314,158 (96.4%)AGAINST: 423,006 (3.6%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to t” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
SR ONE CAPITAL MANAGEMENT, LP	1,048,951	0	For
Versant Venture Management, LLC	500,028	0	For
Jackson National	86,878	196,594	Against
Charles Schwab	0	88,948	Against
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	0	22,300	Against
Global X	0	22,293	Against
ADVISORS SERIES TRUST	17,310	0	For
BlackRock	10,022	0	For
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	0	2,134	Against
JPMorgan	1,394	0	For
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	0	410	Against
Rodgers Brothers Inc.	0	300	Against
Amplify ETF Trust	224	0	For
NORTHCAPE WEALTH MANAGEMENT, LLC	164	0	For
Jacob Funds Inc.	150	0	For
John Hancock	126	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

21. Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.

COMPENSATION

Meeting held 2025-06-05.

Combines 4 wordings of this item as funds reported it.

96% fund support · no official result

FOR 96%

The 30 asset managers below cast 96% of the shares they voted on this item FOR (11,302,518 for, 434,646 against).

FOR: 11,302,518 (96.3%)AGAINST: 434,646 (3.7%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to ” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
SR ONE CAPITAL MANAGEMENT, LP	1,048,951	0	For
Versant Venture Management, LLC	500,028	0	For
Jackson National	86,878	196,594	Against
Charles Schwab	0	88,948	Against
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	0	22,300	Against
Global X	0	22,293	Against
ADVISORS SERIES TRUST	17,310	0	For
BlackRock	0	10,022	Against
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	0	2,134	Against
JPMorgan	0	1,394	Against
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	0	410	Against
Rodgers Brothers Inc.	0	300	Against
Amplify ETF Trust	0	224	Against
NORTHCAPE WEALTH MANAGEMENT, LLC	164	0	For
Jacob Funds Inc.	150	0	For
John Hancock	126	0	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

22. f Non-binding advisory vote on the 2024 Compensation Report.

COMPENSATION

Meeting held 2025-06-05.

68% fund support · no official result

FOR 68%AGAINST 32%

The 30 asset managers below cast 68% of the shares they voted on this item FOR (5,493,924 for, 2,643,047 against).

FOR: 5,493,924 (67.5%)AGAINST: 2,643,047 (32.5%)

Largest asset managers voting on “f Non-binding advisory vote on the 2024 Compensation Report.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	0	1,735,454	Against
State Street	0	233,974	Against
Vanguard	0	221,212	Against
Fidelity	0	151,641	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	0	39,367	Against
Direxion Shares ETF Trust	0	28,769	Against
Northern Trust	0	22,183	Against
MassMutual	0	19,636	Against
American Century	0	16,402	Against
Nationwide	0	16,111	Against
Northwestern Mutual	0	14,200	Against
Blackstone Alternative Investment Funds	0	12,700	Against
Guggenheim	0	7,735	Against
ProShares	0	4,884	Against
Empower	0	2,243	Against
Dimensional	0	1,024	Against
Franklin Templeton	0	737	Against
Vident Advisory, LLC	695	0	For
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	0	263	Against

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

23. Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2024 Compensation Report: 6.a Binding vote on maximum non-performance-related compensation for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.

COMPENSATION

Meeting held 2025-06-05.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 30 asset managers below cast 100% of the shares they voted on this item FOR (8,136,276 for, 0 against).

FOR: 8,136,276 (100.0%)

Largest asset managers voting on “Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory v” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Vote
Capital Group	5,493,229	For
T. Rowe Price	1,735,454	For
State Street	233,974	For
Vanguard	221,212	For
Fidelity	151,641	For
Equitable	56,946	For
Lincoln Financial	55,545	For
RMB INVESTORS TRUST	39,367	For
Direxion Shares ETF Trust	28,769	For
Northern Trust	22,183	For
MassMutual	19,636	For
American Century	16,402	For
Nationwide	16,111	For
Northwestern Mutual	14,200	For
Blackstone Alternative Investment Funds	12,700	For
Guggenheim	7,735	For
ProShares	4,884	For
Empower	2,243	For
Dimensional	1,024	For
Franklin Templeton	737	For
Prudential/PGIM	618	For
WisdomTree	573	For
SA FUNDS INVESTMENT TRUST	354	For
Goldman Sachs	263	For
Invesco	207	For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

24. b Re-election of Ali Behbahani, M.D.

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

70% fund support · no official result

FOR 70%AGAINST 30%

The 29 asset managers below cast 70% of the shares they voted on this item FOR (5,727,410 for, 2,408,866 against).

FOR: 5,727,410 (70.4%)AGAINST: 2,408,866 (29.6%)

Largest asset managers voting on “b Re-election of Ali Behbahani, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	0	1,735,454	Against
State Street	233,974	0	For
Vanguard	0	221,212	Against
Fidelity	0	151,641	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	0	39,367	Against
Direxion Shares ETF Trust	0	28,769	Against
Northern Trust	0	22,183	Against
MassMutual	0	19,636	Against
American Century	0	16,402	Against
Nationwide	0	16,111	Against
Northwestern Mutual	0	14,200	Against
Blackstone Alternative Investment Funds	0	12,700	Against
Guggenheim	0	7,735	Against
ProShares	0	4,884	Against
Empower	0	2,243	Against
Dimensional	0	1,024	Against
Franklin Templeton	0	737	Against
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	0	263	Against
Invesco	207	0	For

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

25. d Re-election of H. Edward Fleming, Jr., M.D.

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

97% fund support · no official result

FOR 97%

The 29 asset managers below cast 97% of the shares they voted on this item FOR (7,889,690 for, 246,586 against).

FOR: 7,889,690 (97.0%)AGAINST: 246,586 (3.0%)

Largest asset managers voting on “d Re-election of H. Edward Fleming, Jr., M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
State Street	233,974	0	For
Vanguard	221,212	0	For
Fidelity	36,226	115,415	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	39,367	0	For
Direxion Shares ETF Trust	28,769	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For
Guggenheim	7,735	0	For
ProShares	4,884	0	For
Empower	2,243	0	For
Dimensional	0	1,024	Against
Franklin Templeton	737	0	For
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	263	0	For
Invesco	207	0	For

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

26. f Re-election of John T. Greene

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

97% fund support · no official result

FOR 97%

The 29 asset managers below cast 97% of the shares they voted on this item FOR (7,853,464 for, 282,812 against).

FOR: 7,853,464 (96.5%)AGAINST: 282,812 (3.5%)

Largest asset managers voting on “f Re-election of John T. Greene” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
State Street	233,974	0	For
Vanguard	221,212	0	For
Fidelity	0	151,641	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	39,367	0	For
Direxion Shares ETF Trust	28,769	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For
Guggenheim	7,735	0	For
ProShares	4,884	0	For
Empower	2,243	0	For
Dimensional	0	1,024	Against
Franklin Templeton	737	0	For
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	263	0	For
Invesco	207	0	For

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

27. k Election of Briggs W. Morrison, M.D.

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

97% fund support · no official result

FOR 97%

The 29 asset managers below cast 97% of the shares they voted on this item FOR (7,892,259 for, 244,017 against).

FOR: 7,892,259 (97.0%)AGAINST: 244,017 (3.0%)

Largest asset managers voting on “k Election of Briggs W. Morrison, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
State Street	233,974	0	For
Vanguard	221,212	0	For
Fidelity	36,226	115,415	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	39,367	0	For
Direxion Shares ETF Trust	28,769	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For
Guggenheim	7,735	0	For
ProShares	4,884	0	For
Empower	2,243	0	For
Dimensional	1,024	0	For
Franklin Templeton	737	0	For
Prudential/PGIM	618	0	For
WisdomTree	573	0	For
SA FUNDS INVESTMENT TRUST	354	0	For
Goldman Sachs	263	0	For
Invesco	207	0	For

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

28. b Re-election of H. Edward Fleming, Jr., M.D.

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

Meeting held 2025-06-05.

97% fund support · no official result

FOR 97%

The 29 asset managers below cast 97% of the shares they voted on this item FOR (7,889,690 for, 246,586 against).

FOR: 7,889,690 (97.0%)AGAINST: 246,586 (3.0%)

Largest asset managers voting on “b Re-election of H. Edward Fleming, Jr., M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
State Street	233,974	0	For
Vanguard	221,212	0	For
Fidelity	36,226	115,415	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	39,367	0	For
Direxion Shares ETF Trust	28,769	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For
Guggenheim	7,735	0	For
ProShares	4,884	0	For
Empower	2,243	0	For
Dimensional	0	1,024	Against
Franklin Templeton	737	0	For
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	263	0	For
Invesco	207	0	For

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

29. c Re-election of John T. Greene

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

Meeting held 2025-06-05.

97% fund support · no official result

FOR 97%

The 29 asset managers below cast 97% of the shares they voted on this item FOR (7,853,464 for, 282,812 against).

FOR: 7,853,464 (96.5%)AGAINST: 282,812 (3.5%)

Largest asset managers voting on “c Re-election of John T. Greene” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
State Street	233,974	0	For
Vanguard	221,212	0	For
Fidelity	0	151,641	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	39,367	0	For
Direxion Shares ETF Trust	28,769	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For
Guggenheim	7,735	0	For
ProShares	4,884	0	For
Empower	2,243	0	For
Dimensional	0	1,024	Against
Franklin Templeton	737	0	For
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	263	0	For
Invesco	207	0	For

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

30. d Election of Briggs W. Morrison, M.D.

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

Meeting held 2025-06-05.

97% fund support · no official result

FOR 97%

The 29 asset managers below cast 97% of the shares they voted on this item FOR (7,892,259 for, 244,017 against).

FOR: 7,892,259 (97.0%)AGAINST: 244,017 (3.0%)

Largest asset managers voting on “d Election of Briggs W. Morrison, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,735,454	0	For
State Street	233,974	0	For
Vanguard	221,212	0	For
Fidelity	36,226	115,415	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	39,367	0	For
Direxion Shares ETF Trust	28,769	0	For
Northern Trust	22,183	0	For
MassMutual	19,636	0	For
American Century	16,402	0	For
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	12,700	0	For
Guggenheim	7,735	0	For
ProShares	4,884	0	For
Empower	2,243	0	For
Dimensional	1,024	0	For
Franklin Templeton	737	0	For
Prudential/PGIM	618	0	For
WisdomTree	573	0	For
SA FUNDS INVESTMENT TRUST	354	0	For
Goldman Sachs	263	0	For
Invesco	207	0	For

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

31. b Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.

COMPENSATION

Meeting held 2025-06-05.

94% fund support · no official result

FOR 94%

The 29 asset managers below cast 94% of the shares they voted on this item FOR (7,635,060 for, 501,216 against).

FOR: 7,635,060 (93.8%)AGAINST: 501,216 (6.2%)

Largest asset managers voting on “b Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,732,530	2,924	For
State Street	0	233,974	Against
Vanguard	221,212	0	For
Fidelity	151,641	0	For
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	0	39,367	Against
Direxion Shares ETF Trust	0	28,769	Against
Northern Trust	0	22,183	Against
MassMutual	19,636	0	For
American Century	0	16,402	Against
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	0	12,700	Against
Guggenheim	0	7,735	Against
ProShares	0	4,884	Against
Empower	2,243	0	For
Dimensional	0	1,024	Against
Franklin Templeton	0	737	Against
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	0	263	Against
Invesco	207	0	For

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

32. c Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026.

COMPENSATION

Meeting held 2025-06-05.

92% fund support · no official result

FOR 92%8%

The 29 asset managers below cast 92% of the shares they voted on this item FOR (7,483,212 for, 653,064 against).

FOR: 7,483,212 (92.0%)AGAINST: 653,064 (8.0%)

Largest asset managers voting on “c Binding vote on maximum non-performance-related compensation for members of the Executive Committee from Jul” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,732,530	2,924	For
State Street	0	233,974	Against
Vanguard	221,212	0	For
Fidelity	0	151,641	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	0	39,367	Against
Direxion Shares ETF Trust	0	28,769	Against
Northern Trust	0	22,183	Against
MassMutual	19,636	0	For
American Century	0	16,402	Against
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	0	12,700	Against
Guggenheim	0	7,735	Against
ProShares	0	4,884	Against
Empower	2,243	0	For
Dimensional	0	1,024	Against
Franklin Templeton	0	737	Against
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	0	263	Against
Invesco	0	207	Against

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

33. d Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025.

COMPENSATION

Meeting held 2025-06-05.

92% fund support · no official result

FOR 92%8%

The 29 asset managers below cast 92% of the shares they voted on this item FOR (7,483,212 for, 653,064 against).

FOR: 7,483,212 (92.0%)AGAINST: 653,064 (8.0%)

Largest asset managers voting on “d Binding vote on maximum variable compensation for members of the Executive Committee for the current year en” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,732,530	2,924	For
State Street	0	233,974	Against
Vanguard	221,212	0	For
Fidelity	0	151,641	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	0	39,367	Against
Direxion Shares ETF Trust	0	28,769	Against
Northern Trust	0	22,183	Against
MassMutual	19,636	0	For
American Century	0	16,402	Against
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	0	12,700	Against
Guggenheim	0	7,735	Against
ProShares	0	4,884	Against
Empower	2,243	0	For
Dimensional	0	1,024	Against
Franklin Templeton	0	737	Against
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	0	263	Against
Invesco	0	207	Against

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

34. e Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.

COMPENSATION

Meeting held 2025-06-05.

89% fund support · no official result

FOR 89%11%

The 29 asset managers below cast 89% of the shares they voted on this item FOR (7,262,000 for, 874,276 against).

FOR: 7,262,000 (89.3%)AGAINST: 874,276 (10.7%)

Largest asset managers voting on “e Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting t” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	1,732,530	2,924	For
State Street	0	233,974	Against
Vanguard	0	221,212	Against
Fidelity	0	151,641	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	0	39,367	Against
Direxion Shares ETF Trust	0	28,769	Against
Northern Trust	0	22,183	Against
MassMutual	19,636	0	For
American Century	0	16,402	Against
Nationwide	0	16,111	Against
Northwestern Mutual	14,200	0	For
Blackstone Alternative Investment Funds	0	12,700	Against
Guggenheim	0	7,735	Against
ProShares	0	4,884	Against
Empower	2,243	0	For
Dimensional	0	1,024	Against
Franklin Templeton	0	737	Against
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	0	263	Against
Invesco	0	207	Against

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

35. Election or Re-election of the members of the Compensation Committee: 5.a Re-election of Ali Behbahani, M.D.

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

Meeting held 2025-06-05.

70% fund support · no official result

FOR 70%AGAINST 30%

The 29 asset managers below cast 70% of the shares they voted on this item FOR (5,727,203 for, 2,409,073 against).

FOR: 5,727,203 (70.4%)AGAINST: 2,409,073 (29.6%)

Largest asset managers voting on “Election or Re-election of the members of the Compensation Committee: 5.a Re-election of Ali Behbahani, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
Capital Group	5,493,229	0	For
T. Rowe Price	0	1,735,454	Against
State Street	233,974	0	For
Vanguard	0	221,212	Against
Fidelity	0	151,641	Against
Equitable	0	56,946	Against
Lincoln Financial	0	55,545	Against
RMB INVESTORS TRUST	0	39,367	Against
Direxion Shares ETF Trust	0	28,769	Against
Northern Trust	0	22,183	Against
MassMutual	0	19,636	Against
American Century	0	16,402	Against
Nationwide	0	16,111	Against
Northwestern Mutual	0	14,200	Against
Blackstone Alternative Investment Funds	0	12,700	Against
Guggenheim	0	7,735	Against
ProShares	0	4,884	Against
Empower	0	2,243	Against
Dimensional	0	1,024	Against
Franklin Templeton	0	737	Against
Prudential/PGIM	0	618	Against
WisdomTree	0	573	Against
SA FUNDS INVESTMENT TRUST	0	354	Against
Goldman Sachs	0	263	Against
Invesco	0	207	Against

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

36. Election of the member of the Compensation Committee: Briggs W. Morrison, M.D.

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

97% fund support · no official result

FOR 97%

The 27 asset managers below cast 97% of the shares they voted on this item FOR (9,920,475 for, 267,947 against).

FOR: 9,920,475 (97.4%)AGAINST: 267,947 (2.6%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Election of the member of the Compensation Committee: Briggs W. Morrison, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Jackson National	105,532	177,940	Against
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
ADVISORS SERIES TRUST	17,310	0	For
BlackRock	10,022	0	For
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	2,134	0	For
JPMorgan	1,394	0	For
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	410	0	For
EXENCIAL WEALTH ADVISORS, LLC	318	0	For
Amplify ETF Trust	224	0	For
Sterling Investment Counsel, LLC	200	0	For
Summit Trail Advisors, LLC	193	0	For
Jacob Funds Inc.	150	0	For
John Hancock	126	0	For
BIRCHBROOK, INC.	100	0	For

Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.

37. Re-election of the member of the Compensation Committee: H. Edward Fleming, Jr., M.D.

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

Combines 2 wordings of this item as funds reported it.

96% fund support · no official result

FOR 96%

The 27 asset managers below cast 96% of the shares they voted on this item FOR (9,810,315 for, 378,107 against).

FOR: 9,810,315 (96.3%)AGAINST: 378,107 (3.7%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Re-election of the member of the Compensation Committee: H. Edward Fleming, Jr., M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Jackson National	86,878	196,594	Against
Charles Schwab	0	88,948	Against
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
ADVISORS SERIES TRUST	17,310	0	For
BlackRock	10,022	0	For
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	0	2,134	Against
JPMorgan	1,394	0	For
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	410	0	For
EXENCIAL WEALTH ADVISORS, LLC	318	0	For
Amplify ETF Trust	0	224	Against
Sterling Investment Counsel, LLC	0	200	Against
Summit Trail Advisors, LLC	193	0	For
Jacob Funds Inc.	150	0	For
John Hancock	126	0	For
BIRCHBROOK, INC.	100	0	For

Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.

38. Re-election of the member of the Compensation Committee: John T. Greene

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

Combines 2 wordings of this item as funds reported it.

96% fund support · no official result

FOR 96%

The 27 asset managers below cast 96% of the shares they voted on this item FOR (9,800,293 for, 388,129 against).

FOR: 9,800,293 (96.2%)AGAINST: 388,129 (3.8%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Re-election of the member of the Compensation Committee: John T. Greene” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Jackson National	86,878	196,594	Against
Charles Schwab	0	88,948	Against
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
ADVISORS SERIES TRUST	17,310	0	For
BlackRock	0	10,022	Against
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	0	2,134	Against
JPMorgan	1,394	0	For
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	410	0	For
EXENCIAL WEALTH ADVISORS, LLC	318	0	For
Amplify ETF Trust	0	224	Against
Sterling Investment Counsel, LLC	0	200	Against
Summit Trail Advisors, LLC	193	0	For
Jacob Funds Inc.	150	0	For
John Hancock	126	0	For
BIRCHBROOK, INC.	100	0	For

Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.

39. Election of Briggs W. Morrison, M.D.

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

Combines 4 wordings of this item as funds reported it.

97% fund support · no official result

FOR 97%

The 26 asset managers below cast 97% of the shares they voted on this item FOR (9,962,554 for, 267,947 against).

FOR: 9,962,554 (97.4%)AGAINST: 267,947 (2.6%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Election of Briggs W. Morrison, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Jackson National	105,532	177,940	Against
Charles Schwab	88,948	0	For
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
Green Alpha Advisors, LLC	40,320	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	22,300	0	For
Global X	22,293	0	For
ADVISORS SERIES TRUST	17,310	0	For
BlackRock	10,022	0	For
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
WILLIAMSBURG INVESTMENT TRUST	2,500	0	For
Allianz	2,134	0	For
JPMorgan	1,394	0	For
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	410	0	For
Amplify ETF Trust	224	0	For
Jacob Funds Inc.	150	0	For
John Hancock	126	0	For
Listed Funds Trust	98	0	For
MARCO INVESTMENT MANAGEMENT LLC	70	0	For

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

40. Re-election of the member of the Compensation Committee: Ali Behbahani, M.D.

DIRECTOR ELECTIONS

Meeting held 2025-06-05.

95% fund support · no official result

FOR 95%

The 26 asset managers below cast 95% of the shares they voted on this item FOR (9,666,688 for, 521,540 against).

FOR: 9,666,688 (94.9%)AGAINST: 521,540 (5.1%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “Re-election of the member of the Compensation Committee: Ali Behbahani, M.D.” at CRISPR THERAPEUTICS AG, 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	9,517,585	0	For
Jackson National	0	283,472	Against
Charles Schwab	0	88,948	Against
Natixis	0	83,372	Against
AMERICAN BEACON FUNDS	53,357	0	For
ARK Venture Fund	38,162	0	For
Investment Managers Series Trust II	33,268	0	For
Capitol Series Trust	0	22,300	Against
Global X	0	22,293	Against
ADVISORS SERIES TRUST	17,310	0	For
BlackRock	0	10,022	Against
Loomis Sayles	0	6,635	Against
EA Series Trust	2,840	0	For
BRANDYWINE OAK PRIVATE WEALTH LLC	2,500	0	For
Allianz	0	2,134	Against
JPMorgan	0	1,394	Against
L. Roy Papp & Associates, LLP	1,000	0	For
CITY NATIONAL ROCHDALE FUNDS	0	410	Against
EXENCIAL WEALTH ADVISORS, LLC	318	0	For
Amplify ETF Trust	0	224	Against
Sterling Investment Counsel, LLC	0	200	Against
Jacob Funds Inc.	150	0	For
John Hancock	0	126	Against
BIRCHBROOK, INC.	100	0	For
Listed Funds Trust	98	0	For

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

Showing the 40 reported items with the widest manager coverage, of 50 in total. View every item.

Largest CRISPR THERAPEUTICS AG shareholders voting in 2024-2025

Ranked by the number of CRISPR THERAPEUTICS AG shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 86,360,924 shares outstanding at the time of that meeting.

Top CRISPR THERAPEUTICS AG shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Capital Group	13.50%
2	ARK ETF Trust	11.02%
3	T. Rowe Price	5.11%
4	Nikko Asset Management Co., Ltd.	2.94%
5	NEA Management Company, LLC	1.84%
6	EcoR1 Capital, LLC	1.61%
7	SR ONE CAPITAL MANAGEMENT, LP	1.21%
8	Loomis Sayles	0.78%
9	State Street	0.65%
10	Versant Venture Management, LLC	0.58%

Reported CRISPR THERAPEUTICS AG ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CRISPR THERAPEUTICS AG beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
ARK Investment Management LLC	13.10%	13G
Capital Research and Management Company	9.52%	DEF14A
ORBIS INVESTMENT MANAGEMENT LTD	7.05%	13G
Capital World Investors	5.71%	13G
BlackRock	3.03%	13F
State Street	2.79%	13F
FMR (Fidelity)	2.25%	13F
Vanguard Group	2.05%	13F
Samarth Kulkarni, Ph.D.	1.70%	DEF14A
Morgan Stanley	1.51%	13F

Percentages above are of 86,360,924 shares outstanding, as reported by CRISPR THERAPEUTICS AG on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CRISPR THERAPEUTICS AG’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At CRISPR THERAPEUTICS AG's shareholder meeting held 2025-06-05, in the 2024-2025 proxy season, 449 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,275 separate fund positions. Their filings are grouped here into 50 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. CRISPR THERAPEUTICS AG's own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Non-binding advisory vote on the compensation paid to the Company's named executive officers… — the reporting funds cast 69% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

CRISPR THERAPEUTICS AG proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.